[ Price : $8.95]
FDA grants AstraZeneca a breakthrough therapy designation for Tagrisso (osimertinib) for the first-line treatment of patients with...[ Price : $8.95]
FDA awards six new research grants ($6.3 million) for natural history studies in rare diseases that are intended to evaluate how t...[ Price : $8.95]
Federal Register notice: FDA announces a 11/2 public meeting entitled Animal Generic Drug User Fee Act.[ Price : $8.95]
FDA clears a Game Ready 510(k) for its orthopedic rehabilitation device, the Med4 Elite.[ Price : $8.95]
Federal Register notice: FDA announces a 11/2 public meeting entitled Animal Drug User Fee Act.[ Price : $8.95]
Federal Register notice: FDA determines the regulatory review period for patent extension purposes for Abiomed Europes Impella 2.5...[ Price : $8.95]
Federal Register notice: FDA determines the regulatory review period for patent extension purposes for Bayers Kovaltry (antihemoph...[ Price : $8.95]
FDA approves a Flexion Therapeutics NDA for Zilretta (triamcinolone acetonide extended-release injectable suspension), an extended...